Literature DB >> 10413509

Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site Tyr992.

M R Holbrook1, J B O'Donnell, L L Slakey, D J Gross.   

Abstract

This study examines the effects of mutations at and in the vicinity of tyrosine 992 of the epidermal growth factor receptor (EGFr) on epidermal growth factor- (EGF-) stimulated internalization of the receptor. Two regions of the EGFr adjacent to this domain have been defined previously as internalization domains. The present work shows that the mutation of negatively charged amino acid residues near Tyr992 to their uncharged analogues increases the rate of EGF receptor internalization. In addition, the conversion of Tyr992, which is an EGFr ligand-induced autophosphorylation site, to phenylalanine also increases the rate of receptor internalization. However, the mutation of Tyr992 to a glutamate residue does not alter the receptor internalization rate. In addition, the truncation of the EGFr at glutamate 996 reduces the internalization rate by half. This result confirms previous reports that residues immediately C-terminal to Glu996 are necessary to allow the normal rate of ligand-induced receptor endocytosis. The data suggest that negative charge in the vicinity of Tyr992, and potentially the phosphorylation of the EGFr at Tyr992, reduces the rate of ligand-induced receptor endocytosis. This reduction in internalization rate increases the lifetime of the activated EGFr in the plasma membrane by about 70%, thus suggesting that phosphorylation of Tyr992 acts to increase the signaling capacity of the EGF receptor even as it directly acts as an SH2 binding site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413509     DOI: 10.1021/bi990195r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.

Authors:  M R Holbrook; L L Slakey; D J Gross
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

2.  The role of endocytosis in regulating L1-mediated adhesion.

Authors:  K E Long; H Asou; M D Snider; V Lemmon
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  Significance of Polar Charged Amino Acids in Compound Mutations in EGFR-mutated Patients Treated With First-line Afatinib.

Authors:  Hiroaki Satoh; Yuika Sasatani; Kunihiko Miyazaki; Yoshiharu Sato; Nobuyuki Hizawa
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

4.  Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells.

Authors:  Dominik Hartl; Chuan Hua He; Barbara Koller; Carla A Da Silva; Robert Homer; Chun G Lee; Jack A Elias
Journal:  J Biol Chem       Date:  2008-09-29       Impact factor: 5.157

5.  Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling.

Authors:  Shinya Tasaki; Masao Nagasaki; Hiroko Kozuka-Hata; Kentaro Semba; Noriko Gotoh; Seisuke Hattori; Jun-ichiro Inoue; Tadashi Yamamoto; Satoru Miyano; Sumio Sugano; Masaaki Oyama
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

6.  Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.

Authors:  Parnetta Sutton; Jeffrey A Borgia; Philip Bonomi; Janet M D Plate
Journal:  Mol Cancer       Date:  2013-07-16       Impact factor: 27.401

7.  RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.

Authors:  Zohra Tumur; Shahbaz Katebzadeh; Carlos Guerra; Lokesh Bhushan; Tursun Alkam; Bradley S Henson
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

8.  Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation.

Authors:  Susie I Ymer; Sameer A Greenall; Anna Cvrljevic; Diana X Cao; Jacqui F Donoghue; V Chandana Epa; Andrew M Scott; Timothy E Adams; Terrance G Johns
Journal:  Cancers (Basel)       Date:  2011-04-18       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.